Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

HBI 2026: Investing in Emerging Markets Summit in partnership with the IFC

At HBI 2026, healthcare executives and investors highlighted both the opportunities and the operational complexity involved in succeeding in emerging markets during the Investing in Emerging Markets Summit, held in partnership with the International Finance Corporation (IFC), a development bank which is part of the World Bank Group.
May 21, 2026

Arada acquires Reem Hospital, commits ~$544m to UAE expansion plan

UAE real estate developer Arada has acquired Abu Dhabi-based healthcare provider Reem Hospital from an investor consortium led by private equity firm Investcorp.  Arada is committing AED 2 billion ($544 million) to Reem Hospital, including both the acquisition of the controlling stake and future expansion investments.
May 21, 2026

GHO and CBC merging to form world’s largest specialist healthcare PE firm with $21bn AUM

London-based healthcare-focused private equity (PE) firm GHO (Global Healthcare Opportunities) Capital is merging with Asia’s largest healthcare-focused private markets investor, Singapore-based CBC Group. Once completed the merged entity will be the largest specialist healthcare PE firm in the world, with over $21 billion assets under management (AUM) across medical devices, pharma, diagnostics, healthcare infrastructure, and healthcare IT.
May 21, 2026

CMA issues ultimatum to Welltower over UK care home acquisitions

The UK’s Competition and Markets Authority (CMA) has given US healthcare REIT Welltower a deadline of Thursday May 14th to come up with remedies to allay concerns it has about the effect of its acquisition of UK care homes on competition in certain local UK care markets.
May 14, 2026

Roche acquires PathAI for ~$1.05 billion

Swiss-based multinational healthcare company Roche has agreed to acquire PathAI, a US-based AI-powered digital pathology firm, for ~$1.05 billion. Roche will pay $750 million upfront and additional milestone payments of up to $300 million.
May 14, 2026

ArchiMed to take Esperion private for ~$1 billion

French private equity firm ArchiMed is taking Nasdaq-listed commercial biopharma firm Esperion Therapeutics private for ~$1 billion. Esperion develops cardiometabolic and rare/orphan disease therapies.
May 8, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us